Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack Provides the most potent bactericidal ability that no other PEP antibiotics in ...
BOSTON and SEOUL, Korea, June 6, 2022 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON" or "Company") announced today that the company has successfully completed the GLP toxicology studies of BAL200. The ...
Intron Technology’s 01760 2022 result was driven by strong growth in revenue from electric vehicles and automated vehicles, with consolidated revenue up 52% and net profit up 107%. Together, these two ...
It aims to promote strategic collaborations in global while also highlights its many innovative advances and successful scientific ventures. BOSTON and SEOUL, South Korea, May 9, 2022 /PRNewswire/ -- ...
iNtRON Biotechnology, Inc. engages in the development of novel biopharmaceutical drugs in South Korea. It develops bacteriophage and endolysin based drugs through itLysin and IMPA platform. The ...
Intron provides design services and solutions for Chinese auto electronics and has around 50% market share in the areas that it specializes in. Electronics for new energy vehicles and automated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results